FredericJosephKayeMD
Oncology • Gainesville, FLHead & Neck Cancer, Hematologic Oncology, Thoracic Cancer
Professor, Medicine, University of Florida College of Medicine
Dr. Kaye is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1600 SW Archer Rd
Gainesville, FL 32610Phone+1 352-273-7760Fax+1 352-273-7849
Education & Training
National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1984 - 1987
Icahn School of Medicine at Mount SinaiFellowship, Hematology and Medical Oncology, 1982 - 1984- Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalResidency, Internal Medicine, 1979 - 1982
University of Maryland School of MedicineClass of 1979
Certifications & Licensure
FL State Medical License 2009 - 2025
MD State Medical License 1985 - 2014- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
- Elected Member The American Society for Clinical Investigation, 2001
Clinical Trials
- Bronchoscopic Intratumoral Chemotherapy for Small Cell Lung Cancer (SCLC) Start of enrollment: 2011 Dec 01
- Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer Start of enrollment: 2013 Feb 01
- Bicalutamide to Block TMPRSS2 in Males With COVID-19 Infection Start of enrollment: 2020 Oct 26
Publications & Presentations
PubMed
- 7634 citationsEGFR mutations in lung cancer: correlation with clinical response to gefitinib therapy.J. Guillermo Paez, Pasi A. Jänne, Jeffrey C. Lee, Sean Tracy, Heidi Greulich
Science. 2004-06-04 - 437 citationsIdentification of cellular proteins that can interact specifically with the T/ElA-binding region of the retinoblastoma gene productWilliam G. Kaelin, David C. Pallas, James A. DeCaprio, Frederic J. Kaye, David M. Livingston
Cell. 1991-02-08 - 2869 citationsThe landscape of somatic copy-number alteration across human cancersRameen Beroukhim, Craig H. Mermel, Dale Porter, Guo Wei, Soumya Raychaudhuri
Nature. 2010-02-18
Press Mentions
Advanced Screening Shows Promise in Detecting Lung CancerOctober 22nd, 2015
Grant Support
- Mechanisms Of Oncogene Action In TumorigenesisNational Cancer Institute2010
- Mechanisms Of Oncogene Action In TumorigenesisDivision Of Clinical Sciences - Nci2009
- Mechanisms Of Oncogene Action In TumorigenesisNational Cancer Institute2007–2008
- Mechanisms Of Oncogene Action In TumorigenesisDivision Of Clinical Sciences - Nci1996–2006
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
